Log In
Print this Print this

Staloral Birch

  Manage Alerts
Collapse Summary General Information
Company Stallergenes Greer plc
DescriptionSublingual solution of birch pollen allergen extract
Molecular Target
Mechanism of ActionImmunotherapy
Therapeutic ModalityBiologic
Latest Stage of DevelopmentPhase II
Standard IndicationAllergic conjunctivitis
Indication DetailsTreat birch allergy in patients with associated rhinoconjunctivitis
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today